Beta Alethine in Treating Patients With Myeloma

Clinical trial NCT00006466 · UNKNOWN

Trial details

NCT number: NCT00006466
Sponsor: LifeTime Pharmaceuticals
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma and Plasma Cell Neoplasm Precancerous Condition

Start date: 2000-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.